Tatva Chintan Pharma IPO GMP Today, Tatva Chintan IPO Grey Market Premium Updates | Tatva Chintan Pharma IPO Listing Gain, Latest target, Opening gain
Tatva Chintan Pharma Chem Ltd initial public offer (IPO) is set to open for subscription on July 16 and close on July 20, after it received capital market regulator Sebi’s go-ahead to raise Rs 500 crore through public issue.
Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
Check out Tatva Chintan Pharma IPO grey market premium, Kostak rates, and subject to sauda rates as of today.
Tatva Chintan Pharma IPO Details:
|Issuer||Tatva Chintan Pharma Chem Ltd|
|Issue Type||Book Built Issue IPO|
|Issue Period||Issue Opens: July 16, 2021|
|Issue Closes: July 20, 2021|
|Price Brand||₹1073 to ₹1083 Per Share|
|Issue Size||₹500 Crores|
|Face Value||Rs. 10 per Equity Share|
|Market Lot||13 Shares|
|Maximum Bid amount for Retail||Rs. 2 Lakhs|
|QIB||50% of the issue size|
|NIB||15% of the issue size|
|Retail Individual Bidders||35% of the issue size|
|Fresh Issue||₹ 225 Cr|
|Offer for Sale||₹ 275 Cr|
|Listing at||NSE & BSE|
|Apply With||Upstox Free DEMAT Account|
|Grey Market Price||Tatva Chintan Pharma IPO GMP Today|
|UPCOMING IPO 2021||UPCOMING DIVIDEND|
|UPCOMING BUYBACK||UPCOMING NCD 2021|
|Best Stocks to buy||Latest IPO Grey Market Premium|
UPCOMING IPO IN JULY 2021
Tatva Chintan IPO REVIEW
Tatva Chintan IPO Apply Or Not?
Tatva Chintan IPO GMP
Tatva Chintan Pharma IPO GMP Rates day by day
Tatva Chintan Pharma IPO Grey market premium as on today
|Date||GMP (in INR)||Kostak (in INR)||Subject to Sauda|
|28 July 2021||1140|
|27 July 2021||1150|
|26 July 2021||1150||400||11000|
|25 July 2021||1050|
|24 July 2021||1020||400||8500|
|23 July 2021||1010||400||8500|
|22 July 2021||920||350||8000|
|21 July 2021||915||350||7500|
|20 July 2021||790||350||7000|
|19 July 2021||770||350||7500|
|18 July 2021||720||300||7000|
|17 July 2021||700||300||7000|
|16 July 2021||680||350||7000|
|15 July 2021||630||300||5500|
|14 July 2021||600||300||5500|
|13 July 2021||530||300||5500|
|12 July 2021||575||250||6000|
|11 July 2021||600||300||6000|
|10 July 2021||350|
How to Apply for Tatva Chintan Pharma IPO :
If you’re a new investor Open DEMAT Account for free with Angel Broking and build wealth with the best stock choices. Join 1 million+ family of happy customers.
In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before UPI mandate expiry date. Please reach out to your bank in case funds are not unblocked/released post the mandate expiry date.
Tatva Chintan Pharma IPO Market Lot:
|Lot Size:||Minimum 13 Shares & Maximum 182 Shares|
Tatva Chintan IPO Allotment & Listing:
|Basis of Allotment:||July 26, 2021|
|Refunds:||July 27, 2021|
|Credit to Demat Account:||July 28, 2021|
|Listing Date:||July 29, 2021|
Check:- Tatva Chintan Pharma IPO Allotment Status
– IPO Grey Market Premium (IPO GMP) mention is valid for the specific date as mentioned in the header.
– We are not buying and selling IPO forms on IPO Grey Market.
– Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
– Do not subscribe for IPO by just seeing premium Price as it may change anytime before listing. Subscribe only considering Fundamental of the companies.
– This is only coverage of News related to Grey Market . We don’t deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
IPO GMP rates are provided as sourced from market intelligence. Please note these IPO GMP rates may be different depending on geographies and markets.
We don’t trade into grey market nor do we facilitate buying or selling of IPO forms.
What is Grey Market?
Grey Market is the term used to describe unregulated over-the-counter market for trading IPO applications and IPO shares before the stock is listed at a stock market. This is a way for dealers to support their customers who may want to exit before listing.
This is also a way to boost the listing price and support the issue before listing happens. There are two kinds of transactions that happen in thee IPO grey market:
- Trade of IPO shares at a grey market premium
- Trade of IPO application at a kostak.
What is Grey Market Premium?
GMP or Grey Market Premium is the premium at which equity shares from the IPO are being traded in the grey market.
This could either be a positive or negative – meaning the trading price in the grey market is either higher or lower than issue price respectively, based on demand and supply for the shares.
Typically, investors who do not want to take the risk of allocation not happening through IPO will buy shares in the gray market and hope to flip the shares on listing to make a good profit.
What is Kostak?
Kostak is the premium at which IPO application is being traded in the grey market. Applications are typically traded after the application window is closed but the allotment has not yet been finished.
It is rare for someone to trade IPO application post-allocation. This is a way for investors to increase their chance of shares being allotted as the allocation process treats each retail application equally. An example (indicative) for kostak is:
Tatva Chintan Pharma CHEM Limited
Issue Price: Rs 306 Per Equity Share (Maximum Bid price)
Lot Size: 45
Grey Market Premium: Rs 220 to Rs 230
Kostak (Rs 13770): Rs 680 to Rs 720
This means Tatva Chintan Pharma applications of Rs 13770 are being traded in IPO Grey Market at Rs 680 to Rs 720.
Despite the fact that this IPO’s Grey Market Premium is roughly 75% of the issue price, the ‘Kostak’ is just 5% of the application value.
As can be seen the Kostak is at a much lower %age than GMP. This indicates that the grey market expects the issue to be oversubscribed and expects on an average only one lot to be allocated per application.
Kostak rate is the amount an investor gets by selling his/her IPO application in grey market. This is the amount an investor stands to gain, irrespective of allotment status.
Subject to Sauda simply reflects the amount which an investor stands to get by selling his/her application for firm allotment. The key operative word here is firm allotment. In case of no allotment to the applicant, the sauda stands cancelled.
In case of ‘Subject to Sauda’ deal, while selling IPO application in the grey market, buyer and seller agree that deal is only valid if the seller will get the allotment. If the seller doesn’t get any shares in IPO process, the deal gets avoid.
The Grey Market Premium of Tatva Chintan Pharma IPO is approx. Rs.530 at the moment.
The Subject to Sauda price for Tatva Chintan Pharma IPO is approx. Rs. 5500/-
Tatva Chintan Pharma IPO listing gain will be approx. Rs.6900/- (update on a daily basis)
The Kostak price of Tatva Chintan Pharma IPO is approx. Rs 300/-.
Tatva Chintan Pharma IPO listing date is Jul 29, 2021.